Youth Forum: Your excellencies, distinguished delegates, ladies and gentleman. From 25 countries we gather as a unified voice to address the issue of substance use in our communities. This is not a new challenge and has been tackled over the past decades. Everyday there are new substances threatening individuals and society as a whole. It …
Committee of the Whole – Wednesday afternoon
L3. Promoting research on evidence-based interventions for the treatment and care of stimulant use disorders E/CN.7/2025/L.3 (…) Chair: There are several paragraphs in this document that have been agreed during informals, so we will go through those first. PP1 Agreed in CoW. PP4 Agreed in CoW. PP5 Agreed in CoW PP8 Agreed in CoW PP10 …
Item 6: Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem.
Chair: The Youth Forum and others are still meeting and will report to us this afternoon. Let’s now move to comments from the chair. As you’ll be aware in the Mid Term Review of the 2019 Ministerial Declaration. Member States reaffirm their commitment to the Ministerial Declaration and acknowledge commitment therein for scientific, evidence based …
Informal NGO dialogue with UNODC Executive Director
UNODC ED: I am very pleased to be here despite how busy I am. This meeting is different every year – it is the voice of civil society and the people who have gone the difficult road to be the voice of people who can’t express themselves. We are going through difficult times for multilateralism …
Committee of the Whole – Wednesday morning session
L.5. Safety of officers in dismantling illicit synthetic opioid laboratories OP 2 (c) (…) China: We would like to delete the wording from ‘exposure’ to ‘chemicals’. United States: WE would like to remain faithful to the intention of sponsors, which is in line with our policy. This resolution is for all member states but some …
Item 5. Implementation of the international drug control treaties (continued)
(a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it wishes to include N-pyrrolidino metonitazene in Schedule I of the …